FDA gives 510(k) approval for the HydraSolve autologous fat transfer system (Andrew Technologies) for Lipoplasty
Andrew Technologies has received 510(k) clearance from the FDA for its HydraSolve Lipoplasty system for autologous fat transfer, in which adipose tissue is harvested and can be reinjected into the same patient for rejuvenation or augmentation. HydraSolve achieves liquefaction of fat tissue by cell disaggregation, not by emulsification and the lysing of cell membranes. The system rapidly removes fat and produces a nearly bloodless fat layer of uniform particles that can be easily injected into breasts and other target tissues.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins